Supplementary Figure S3 from Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration

Amei Ludwig; Zachary P. McKay; Griffin P. Carter; Mark A. Katz; Georgia Howell; Vaibhav Jain; Stephanie Arvai; Dirk P. Dittmer; Darell D. Bigner; David M. Ashley; Madison L Shoaf; Annick Desjardins; Simon G. Gregory; Michael C. Brown; Matthias Gromeier

doi:10.1158/2326-6066.31239128

Supplementary Figure S3 from Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration

2026 Open access

Read full text

Authors: Amei Ludwig, Zachary P. McKay, Griffin P. Carter, Mark A. Katz, Georgia Howell, Vaibhav Jain, Stephanie Arvai, Dirk P. Dittmer, Darell D. Bigner, David M. Ashley, Madison L Shoaf, Annick Desjardins

+3 more

Simon G. Gregory, Michael C. Brown, Matthias Gromeier

DOI: 10.1158/2326-6066.31239128

Cited by: 0

Abstract

Supplementary Figure S3. Dual-site (IT+CPLI) PVSRIPO in CT2A-bearing mice changes immune cell composition in cLN (extended data relating to Figure 3).

Fields of Study & Subjects

Virus-based gene therapy research Immunotherapy and Immune Responses Cancer Immunotherapy and Biomarkers

Publication details

Publication date: 3 February 2026